PDLI Related Downgrades
-
Credit Suisse Downgrades PDL BioPharma (PDLI) to Underperform
-
RBC Capital Downgrades PDL BioPharma (PDLI) to Sector Perform, Maintains Price Target
-
Global Hunter Securities Downgrades PDL BioPharma (PDLI) to Accumulate; Valuation Call
-
Lazard Downgrades PDL BioPharma (PDLI) to Hold
-
J.P. Morgan Downgrades PDL BioPharma (PDLI) to Underweight
-
Credit Suisse Downgrades PDL BioPharma (PDLI) to Neutral
-
Wachovia downgrades PDL BioPharma (PDLI) to Market Perform
-
Broadpoint Capital Downgrades PDL BioPharma (PDLI) to Neutral
-
S&P Equity Research Downgrades PDL Biopharma (PDLI) to Hold
-
Lazard Capital Downgrades PDL Biopharma (PDLI) to Hold
-
Lehman Bros. Downgrades PDL BioPharma (PDLI) to Equalweight
-
Pacific Growth Downgrades PDL BioPharma (PDLI) to Neutral
-
CIBC downgrades PDL BioPharma (PDLI) to Sector Perform
-
JP Morgan downgrades PDL BioPharma (PDLI) to Neutral
-
Wachovia Downgrades PDL BioPharma (PDLI) to Market Perform
-
S&P Equity Research Downgrades PDL BioPharma Inc. (PDLI) to Hold
-
First Albany downgrades PDL Biopharma (PDLI) to Underperform
-
Prudential downgrades PDL Biopharma (PDLI) to Neutral
-
First Albany downgrades PDL Biopharma (PDLI) to Neutral
-
Deutsche Bank downgrades PDLI to Hold
-
Citigroup downgrades PDLI to Hold
Back to PDLI Stock Lookup
